handling crisis in or
TRANSCRIPT
Operating Room Critical Event
1. Air Embolism
2. Anaphylaxis
3. Bradycardia – Unstable
4. Cardiac Arrest
5. Failed Airway
6. Fire
7. Haemorrhage
8. Malignant Hyperthermia
9. Local Anaesthetic Toxicity
Debriefing after event
Suspected Events
1. Air Embolism -Decreased end-tidal CO2, decreased oxygen saturation, hypotension, tachycardia, ECG changes
Œ Call for help and get the resuscitation trolley
Who is the leader?
Inform the surgeon
Nitrous oxide stopped? FiO2 increased to 100%
‘ Stop source of air entry
•Wound filled with irrigation or cover in saline soaked swabs
•Surgical site lowered the level of the heart if possible
•Entry point search (including open venous lines)
Consider: • Left side down once source
controlled • Additional monitoring • Fluid bolus • Inotropes - adrenaline +/-
infusion
Additional Considerations: Aspiration air from CVP line
Discontinuation operation
Arrange supportive care in
ICU
Critical CHANGES
? ASYSTOLE/PEA develops
? VT/VF develops
2. Anaphylaxis -Hypotension, bronchospasm, high peak-airway pressures, decreased or lack of breath sounds, tachycardia, urticaria
Œ Call for help and get the resuscitation trolley
Who is the “hands-off” leader?
FiO2 increased to 100% and consider turning off volatile agent
Adrenaline bolus - 50-100mcg and repeated as required
Potential causative agents removed?
‘ Airway established/secured?
’ IV access adequate?
“ IV Fluids bolus
Consider:
Consider additional lines and investigations
Arterial line / Central line
ABG, electrolytes, FBC, Coagulation Screen
Consider antihistamine/steroids
Dexamethasone / Hydrocortisone
Arrange post-operative cares in HDU/ICU
-If bradycardia occurs: invariably heralds
cardiovascular collapse
-Other that may be implemented:
• Blood products
-Referral for allergy testing
Common CAUSATIVE AGENTS
Chlorhexidine
Latex
Antibiotics
Colloids
Neuromuscular blockers
DRUG DOSES and treatments
Adrenaline Bolus: 50-100mcg IV
Infusion: 5mg in 50ml
NS, run at 3-30ml/hr
Noradrenaline Infusion: 4mg in 40ml
NS, run at 3-30ml/hr
Vasopressin Bolus: 1-2 units IV
Infusion: 2units/hr
Salbutamol Bolus: 250mcg IV
Infusion: 5-
25mcg/min
Glucagon 1-5mg over 5 min
Critical CHANGES
? ASYSTOLE/PEA develops
? VT/VF develops
Adrenaline +/- Noradrenaline infusion
Vasopressin
Salbutamol - if resistant bronchospasm
Glucagon – for beta blocker reversal
3. Bradycardia – Unstable -HR <50bpm with hypotension, acutely altered mental state, shock, ischaemic ECG, acute heart failure
Œ Call for help and get the resuscitation trolley
Who is the leader?
Turn FiO2 to 100% and consider turning off volatile agent
Give atropine 0.6mg IV (may repeat up to 3mg)
Stop surgical stimulation (if laparoscopy, desufflate)
‘If atropine ineffective •Start adrenaline infusion
- or -•Start transcutaneous pacing
’ Confirm pulse present - if PEA develops
Consider:
Urgent cardiology consultation
Myocardial infarction
Drug induced causes eg. β/Ca2+
channel blockers, digoxin, LA toxicity
Critical CHANGES
If PEA develops? ASYSTOLE/ PEA
If LA toxicity? LA TOXICITY
During RESUSCITATION
Airway Assess and secure
Circulat
ion
Confirm IV access, IV fluids
wide open
TRANSCUTANEOUS PACING instructions
-Select MANUAL ON on defibrillator
-Apply electrodes and pads & connect
to defibrillator
-Press PACER
-Adjust RATE to 80/min – can adjust
once established
-Press START
-Adjust OUTPUT (mA) until electrical
capture
-Pacer spikes aligned with QRS
complex; normally 65-100mA.
-Set final milliamperes to 10mA
above this level.
-Confirm mechanical capture - cardiac
output
DRUG DOSES and treatments
Adrenaline Infusion: 3-30ml/hr
(5mg in 50mls)
Atropine 0.6mg IV (Max. 3
doses)
OVERDOSE treatments
Beta blocker:
Glucagon
2-4mg IV push
Ca channel blocker:
CaCl2
1g IV
Digoxin:
digoxin immune FAB
10 vials
4a. Cardiac Arrest :Asystole/PEA-Non-shockable pulseless cardiac arrest
Œ Call for help and get the resuscitation trolley
Who is the leader?
Ž Say “CPR”
Start CPR and assessment cycle
Perform CPR •“Hard and fast” compressions 100/min
•Minimal interruptions
•8 breaths/min, do not overinflate Ø Give adrenaline
•Repeat every second cycle Ø Assess every 2 minutes
•Change CPR provider
•Check rhythm; if rhythm is organized, then check pulse
-VF/VT → resume CPR – defibrillation – assessment cycle
-Asystole/PEA → resume CPR and assessment cycle
Critical CHANGES
If VF/VT develops
During CPR
Airway: Assess and secure
Circulation: Confirm IV access, IV fluids
wide open
Assign roles:
Chest compressions, Airway,
Vascular access, Documentation,
Drugs
DRUG DOSES and treatments
Adrenaline 1mg IV, repeat every 2nd
cycle
TOXIN treatment
Local anaesthetic :
Intralipid
-1.5ml/kg IV bolus
-Repeat 1-2 times in
persistent asystole
-Start infusion 0.25-
0.5ml/kg for 60mins for
refractory hypotension
Beta-blocker :
Glucagon
2-4mg IV
Ca channel blocker :
Calcium Chloride
1g IV
HYPERKALAEMIA treatment
Calcium Chloride 1g IV
Insulin 10 u actrapid in 50 ml of
50% dextrose
Sodium bicarbonate 0.5-1mmol/kg slow IV
Reversible clauses: 5Hʼs & 5Tʼs
Hypovolaemia Tension pneumothorax
Hypoxia Tamponade, cardiac
Hyper/
hypokalaemia
Toxins (beta blocker ,Ca2+
channel blocker, local
anaesthetic)
Hypothermia Thrombosis (pulmonary)
Hydrogen ion Thrombosis (coronary)
4b. Cardiac Arrest – VF/VT -Shockable pulseless cardiac arrest
Call for help and the resuscitation trolley
Who is the leader?
� Say “Start CPR and shock patient as soon as defibrillator arrives”
FiO2 100% and stop volatile anaesthetics
Start CPR – defibrillation – assessment cycle -Perform CPR
“Hard and fast” compressions 100/min
Minimal interruptions
-Defibrillate
Shock at 120-200J (Biphasic), 360J (Monophasic)
Resume CPR immediately after shock
-Give adrenaline
Repeat every 2nd cycle
Consider amiodarone (ANTIARRHYTHMICS) after 3rd cycle Ø Assess every 2 minutes
-Change CPR compression provider -Treat reversible causes, consider reading out 5Hʼs & 5Tʼs -Check rhythm; if organised, check pulse
•VF/VT → resume CPR – defibrillation – assessment cycle •Asystole/PEA → resume CPR and assessment cycle
During CPR
-Airway Assess and secure
-Circulation Confirm IV access, IV fluids
wide open
-Assign roles :
Chest compressions, Airway,
Vascular access, Documentation,
Drugs
Reversible clauses: 5Hʼs & 5Tʼs
Hypovolaemia Tension pneumothorax
Hypoxia Tamponade, cardiac
Hyper/
hypokalaemia
Toxins (beta blocker ,Ca2+
channel blocker, local
anaesthetic)
Hypothermia Thrombosis (pulmonary)
Hydrogen ion Thrombosis (coronary)
DRUG DOSES and treatments
Adrenaline 1mg IV, repeat
every 2nd cycle
Amiodarone Bolus: 300mg IV
after 3rd cycle
Infusion: 900mg IV
over 24 hours
Magnesium Bolus: 2g IV for
torsades de pointes
DEFIBRILLATOR instructions
Select ENERGY 120-200J on defibrillator according to manufactor’s
recommendation
Apply pads to chest & connect to defibrillator
Consider SYNC shock if VT
Press CHARGE
Say “Stand Clear” and press SHOCK
Synchronised Cardioversion:
• Requires defibrillator ECG to be attached to the patient
• Pads will not discharge immediately as QRS complex needs to be detected
• Keep the SYNC button pressed until shock delivered
TACHYCARDIA RHYTHMS where synchronisation indicated:
• Atrial fibrillation
• Mono-morphic VT
• Other SVT, atrial flutter
5. Failed Airway -2 unsuccessful intubation attempts by an airway expert with
adequate muscle relaxation
Œ Call for help and consider calling for surgical/ENT assistance
Get difficult intubation trolley and the Glidescope
Who is the leader?
Bag-mask ventilate with 100% O2
“The top priority is oxygenation”‘ Is ventilation adequate?
NOT ADEQUATE Remains NOT ADEQUATE
Ø Optimise Ventilation • Reposition patient
• Oral airway/nasal airway
• Two-handed mask
Ø Check equipment • Using 100% O2
• Capnography
• Circuit
Ø Check ventilation
Place laryngeal mask airway
(LMA/iLMA)
If unsuccessful, attempt intubation
using video laryngoscope
Prepare for surgical airway Ø Paralysis
adequate?
Consider
• Urgency of surgery
• Aspiration risk
• Airway swelling
• Obstetrics - fetal status
Ventilation still NOT ADEQUATE
Implement surgical airway (Tracheostomy)/Cricothyrotomy
If ventilation status changes
awakening patient
OR
alternative approaches
to secure airway
Alternative approaches to secure airway
• Operation using LMA, face mask
• Video laryngoscope
• LMA as conduit to intubation
• Return to spontaneous ventilation
• Different blades
• Intubating stylet
• Fiberoptic intubation
• Retrograde intubation
• Blind oral or nasal intubation
6. Fire -Surgical fire: Evidence of fire (smoke, odour, flash) on patient
or drapes, or in patient's airway
-Environmental fire: Evidence of fire (smoke, odour, flash) in OT/surrounding areaŒ
Call for help
Who is the leader?
Extinguish of fire / Evacuation
For AIRWAY fire
Attempt to extinguish fire •Shut off medical gases •Disconnect ventilator •Remove ETT and flammable material from airway •Pour saline into airway After fire extinguished 1. Re-establish ventilation using self-inflating bag with room air management plan • Re-establish ventilation • Avoid NO2 and minimize FIO2 2. Confirm no secondary fire 3. Equipment•Check surgical field, drapes and towels materials/devices for review •Assess airway for injury or foreign body •Assess ETT integrity (fragments may be left in airway) •Consider bronchoscopy Assess patient status and devise ongoing plan Save involved materials/devices for review
For NON-AIRWAY fire
•• Follow Fire Diaster Plan and department protocol
7. Haemorrhage-Acute massive bleeding
Œ Call for help
Who will be the leader?
Open IV fluids and assess for adequate IV access
FiO2 100%
Inform blood bank
-If shocked & uncontrolled bleeding → massive transfusion protocol
-If controlled bleeding → ask for 4 units RBC / according to anaesthetists'order
-If no group and screen → ask for unmatched blood (O negative)
‘ Request rapid infuser or fluid warmer and pressure bags
’ Discuss management plan among surgical, anaesthesia and nursing teams
“ Keep patient warm
” Send ABG or venous blood sample, repeat regularly
TRANSFUSION Goals
MAP >50 but do not normalize until surgical control
Fibrinogen >2.0g/L
Red blood Cells >70g/L
Platelets >50 x 109/L
Adverse effect of massive blood transfusion and treatments
Hypocalcemia Calcium Chloride 10% 10ml IV. Repeat as required
Hyperkalemia Insulin
10u actrapid in 50 ml 50%
Dextrose
AcidosisSodium bicarbonate
0.5-1 mmol/kg IV to maintain
ph>7.2
ANTIFIBRINOLYTIC Tranexamic acid
1g IV over 10min then 1g over 8
hrs
8. Malignant Hyperthermia -In presence of triggering agent: unexpected increase in end-
tidal CO2, unexplained tachycardia/tachypnoea. Prolonged masseter muscle spasm after succinylcholine. Hyperthermia is a late sign.
Call for help and notify surgeon
Who will be the leader?
Get Malignant Hyperthermia (MH) Box
Assign task cards to individuals
ŽSay “Dantrolene administration is the priority”
Turn off volatile agent and remove triggering agents
Hyperventilate with 100% oxygen and high fresh gas flows (>15L/min)
Add vapour-clean filters. Do not change machine.
‘ Commence non triggering anaesthesia
’ Dantrolene administration in progress?
“ Lines and investigations (ABG) in progress?
” Patient cooling: Cold IV fluids running + ice pad + cold irrigation
Simultaneously treat life threatening effects:
Hyperthermia / Acidosis / Hyperkalaemia / Arrhythmias
9. Local Anaesthetic Toxicity -Sudden alteration in mental status, Numbness of tongue,tonic-
clonic seizure, cardiovascular arrhythmias or collapse
Œ Stop injecting the local anaesthetic
Call for help (Crash call)Resuscitation trolley
Intralipid
Who is the leader?
FiO2 increased to 100% and secure airway
‘ Control seizures with midazolam or propofol
’ Assess cardiovascular status Circulatory arrest
Start CPR – defibrillation – assessment cycle
Administer Intralipid
Manage arrhythmias
If not in circulatory arrest
Treat hypotension, bradycardia, tachyarrhythmias
Consider Intralipid
DRUG DOSES and treatments
Adrenaline1mg IV, repeat
every 2nd cycle
Amiodarone Bolus: 300mg IV
after 3rd cycle
Infusion: 900mg
IV over 24 hours
Atropine Bolus: 0.6mg IV
Intralipid 1.5ml/kg IV bolus
X Propofol is not a
substitute for
intralipid
X Avoid using
lignocaine
Debriefing after a critical incident - Reflection of facts and processes, sharing emotions, learning experience, reporting Who is the “debriefer” – the chair of the meeting?
State the confidentiality of the meeting
Identify and introduce each member of the team
•Say “All should have an opportunity to contribute.”
Invite sharing of emotional reactions
•Recognise and acknowledge stress
Clarifying what happened
•Try to establish what happened during the incident response
What are the learning points and any changes for the future?
•Consider review of structure/processes
•Consider review of policy/guidelines
•Further education
Discuss reporting/investigation of the event
Reporting Channel
Conclude by restating confidentiality of the debriefing